Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Weaver

Showing results (91-100 of 173) with videos related to

Pageof 18
Sort By:
Molecular Pharmacology|August 27, 2009
High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1L Michelle Lewis, Gautam Bhave, Brian A Chauder, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: a putative potassium channel opener with bladder-relaxant propertiesSvetlana Tertyshnikova, Ronald J Knox, Mary Jane Plym, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2019
Sign Inversion in Photopharmacology: Incorporation of Cyclic Azobenzenes in Photoswitchable Potassium Channel Blockers and OpenersJulie B Trads, Katharina Hüll, Bryan S Matsuura, et al.
EMBO Molecular Medicine|July 11, 2023
MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humansAniko Gal, Peter Balicza, David Weaver, et al.
Molecular Microbiology|November 30, 2005
Cross-regulation among disparate antibiotic biosynthetic pathways of Streptomyces coelicolorJianqiang Huang, Jing Shi, Virginie Molle, et al.
RSC Medicinal Chemistry|August 30, 2021
Discovery, synthesis and biological characterization of a series of <i>N</i>-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1<i>H</i>-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activatorsSwagat Sharma, Lauren Lesiak, Christopher D Aretz, et al.
Bioorganic & Medicinal Chemistry Letters|September 9, 2008
Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channelsRobert G Gentles, Katherine Grant-Young, Shuanghua Hu, et al.
Organic & Biomolecular Chemistry|December 1, 2016
Optical control of GIRK channels using visible lightJulie B Trads, Jessica Burgstaller, Laura Laprell, et al.
Molecular Pharmaceutics|April 19, 2005
A novel high-throughput pepT1 transporter assay differentiates between substrates and antagonistsTeresa N Faria, Julita K Timoszyk, Terry R Stouch, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2008
Preliminary SAR studies on non-apamin-displacing 4-(aminomethylaryl)pyrrazolopyrimidine K(Ca) channel blockersRobert G Gentles, Shuanghua Hu, Yazhong Huang, et al.
Pageof 18

Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
Molecular Pharmacology|August 27, 2009
High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1L Michelle Lewis, Gautam Bhave, Brian A Chauder, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: a putative potassium channel opener with bladder-relaxant propertiesSvetlana Tertyshnikova, Ronald J Knox, Mary Jane Plym, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2019
Sign Inversion in Photopharmacology: Incorporation of Cyclic Azobenzenes in Photoswitchable Potassium Channel Blockers and OpenersJulie B Trads, Katharina Hüll, Bryan S Matsuura, et al.
EMBO Molecular Medicine|July 11, 2023
MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humansAniko Gal, Peter Balicza, David Weaver, et al.
Molecular Microbiology|November 30, 2005
Cross-regulation among disparate antibiotic biosynthetic pathways of Streptomyces coelicolorJianqiang Huang, Jing Shi, Virginie Molle, et al.
RSC Medicinal Chemistry|August 30, 2021
Discovery, synthesis and biological characterization of a series of <i>N</i>-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1<i>H</i>-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activatorsSwagat Sharma, Lauren Lesiak, Christopher D Aretz, et al.
Bioorganic & Medicinal Chemistry Letters|September 9, 2008
Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channelsRobert G Gentles, Katherine Grant-Young, Shuanghua Hu, et al.
Organic & Biomolecular Chemistry|December 1, 2016
Optical control of GIRK channels using visible lightJulie B Trads, Jessica Burgstaller, Laura Laprell, et al.
Molecular Pharmaceutics|April 19, 2005
A novel high-throughput pepT1 transporter assay differentiates between substrates and antagonistsTeresa N Faria, Julita K Timoszyk, Terry R Stouch, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2008
Preliminary SAR studies on non-apamin-displacing 4-(aminomethylaryl)pyrrazolopyrimidine K(Ca) channel blockersRobert G Gentles, Shuanghua Hu, Yazhong Huang, et al.
Pageof 18